D-0294-2022 Class II Terminated
FDA drug recall D-0294-2022 was initiated by Teva Pharmaceuticals USA on Dec 16, 2021 and is designated Class II. Reason for recall: Subpotent The recall status is terminated (terminated Nov 4, 2022). Affected quantity: a) 86,790 and b) 25,416 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 29, 2021
- Initiation Date
- Dec 16, 2021
- Termination Date
- Nov 4, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 86,790 and b) 25,416 bottles
Product description
Penicillin V Potassium for Oral Solution, USP 125 mg (200,000 U) per 5 mL a) 100 mL (NDC 00093-4125-73) and b) 200 mL (NDC 00093-4125-74) (when mixed) bottles, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454
Reason for recall
Subpotent
Distribution pattern
nationwide
Code information
a) Lots, 35446365A, Exp 03/2022; 35447040A, Exp 08/2022 & 35447948B, Exp 03/2023. b) Lots 35446318B, Exp 05/2022 & 35447947A, Exp 03/2023.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0294-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026